Tom Gayner’s Bristol-Myers Squibb BMY Stock Holding History

Tom Gayner’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,000	Closed	-$632K	–	139
2018 Q1	$632K	Hold	10,000	–	–	0.01%	130
2017 Q4	$613K	Hold	10,000	–	–	0.01%	132
2017 Q3	$637K	Hold	10,000	–	–	0.01%	132
2017 Q2	$557K	Hold	10,000	–	–	0.01%	130
2017 Q1	$544K	Hold	10,000	–	–	0.01%	128
2016 Q4	$584K	Hold	10,000	–	–	0.01%	128
2016 Q3	$539K	Hold	10,000	–	–	0.01%	122
2016 Q2	$735K	Hold	10,000	–	–	0.02%	123
2016 Q1	$639K	Hold	10,000	–	–	0.02%	126
2015 Q4	$688K	Buy	+10,000	New	+$661K	0.02%	121

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tom Gayner's BMY Position: Q2 2018 in Review

Tom Gayner sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 10,000 shares — an estimated $632K sold.

Tom Gayner first reported a position in BMY in Q4 2015 and held it in 10 quarters. The position peaked at $735K in Q2 2016. 1,692 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

Tom Gayner reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
Tom Gayner sold 10,000 Bristol-Myers Squibb shares in Q2 2018, an estimated $632K.
Tom Gayner first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 10 quarters.
Tom Gayner's Bristol-Myers Squibb position peaked at $735K in Q2 2016.
1,692 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Markel Group's 13F filing for Q2 2018, filed 3 Aug 2018.